Shen Xiao Yun, Zacal Natalie, Singh Gurmit, Rainbow Andrew J
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
Photochem Photobiol. 2005 Mar-Apr;81(2):306-13. doi: 10.1562/2004-07-22-RA-242.
Photodynamic therapy (PDT) is a novel cancer therapy inducing irreversible photodamage to tumor tissue via photosensitizer-mediated oxidative cytotoxicity. The cellular and molecular responses associated with PDT are only partially understood. We have reported previously the generation of several photosensitizer-specific PDT-resistant cell variants of HT29 human colon adenocarcinoma cells by selecting cells from sequential PDT treatment using different photosensitizers. In this report, we describe the use of messenger RNA (mRNA) differential display to identify genes that were differentially expressed in the parental HT29 cells compared with their resistant variants. In comparison with parental HT29 cells, mRNA expression was increased in the PDT-resistant cell variants for BNIP3, estrogen receptor-binding fragment-associated gene 9, Myh-1c, cytoplasmic dynein light chain 1, small membrane protein I and differential dependent protein. In contrast, expression in the PDT-resistant variants was downregulated for NNX3, human HepG2 3' region Mbol complementary DNA, glutamate dehydrogenase, hepatoma-derived growth factor and the mitochondrial genes coding for 16S ribosomal RNA (rRNA) and nicotinamide adenine dinucleotide (NADH) dehydrogenase subunit 4. The reduction for mitochondrial 16S rRNA in the PDT-resistant variants was confirmed by Northern blotting, and the elevated expression of the proapoptotic BNIP3 in the PDT-resistant variants was confirmed by Northern and Western blotting analysis. We also examined the expression of some additional apoptosis-regulating genes using Western blotting. We show an increased expression of Bcl-2 and heat shock protein 27 and a downregulation of Bax in the PDT-resistant variants. In addition, the mutant p53 levels in the parental HT29 cells were reduced substantially in the PDT-resistant variants. We suggest that the altered expression in several mitochondrial and apoptosis-regulating genes contributes to PDT resistance.
光动力疗法(PDT)是一种新型癌症治疗方法,通过光敏剂介导的氧化细胞毒性对肿瘤组织产生不可逆的光损伤。与PDT相关的细胞和分子反应仅得到部分了解。我们之前报道过,通过使用不同光敏剂对HT29人结肠腺癌细胞进行连续PDT处理后筛选细胞,产生了几种对光敏剂特异性耐药的细胞变体。在本报告中,我们描述了使用信使核糖核酸(mRNA)差异显示技术来鉴定与亲本HT29细胞相比,在其耐药变体中差异表达的基因。与亲本HT29细胞相比,BNIP3、雌激素受体结合片段相关基因9、Myh-1c、细胞质动力蛋白轻链1、小膜蛋白I和差异依赖性蛋白在PDT耐药细胞变体中的mRNA表达增加。相反,NNX3、人HepG2 3'区域Mbol互补DNA、谷氨酸脱氢酶、肝癌衍生生长因子以及编码16S核糖体RNA(rRNA)和烟酰胺腺嘌呤二核苷酸(NADH)脱氢酶亚基4的线粒体基因在PDT耐药变体中的表达下调。通过Northern印迹法证实了PDT耐药变体中线粒体16S rRNA的减少,通过Northern和Western印迹分析证实了PDT耐药变体中促凋亡BNIP3的表达升高。我们还使用Western印迹法检测了一些其他凋亡调节基因的表达。我们发现PDT耐药变体中Bcl-2和热休克蛋白27的表达增加,而Bax的表达下调。此外,亲本HT29细胞中的突变型p53水平在PDT耐药变体中大幅降低。我们认为,几种线粒体和凋亡调节基因的表达改变导致了PDT耐药性。